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he cytoskeletal changes that alter cellular morpho-
genesis and motility depend upon a complex interplay
among molecules that regulate actin, myosin, and
other cytoskeletal components. The Rho family of GTP
binding proteins are important upstream mediators of
cytoskeletal organization. Gem and Rad are members of
another family of small GTP binding proteins (the Rad,
Gem, and Kir family) for which biochemical functions have
been mostly unknown. Here we show that Gem and Rad
interface with the Rho pathway through association with
the Rho effectors, Rho kinase (ROK) 
 
 
 
 and 
 
 
 
. Gem binds
 
ROK
 
 
 
 independently of RhoA in the ROK
 
 
 
 coiled-coil
 
region adjacent to the Rho binding domain. Expression of
Gem inhibited ROK
 
 
 
-mediated phosphorylation of myosin
light chain and myosin phosphatase, but not LIM kinase,
T
 
suggesting that Gem acts by modifying the substrate speciﬁcity
of ROK
 
 
 
. Gem or Rad expression led to cell ﬂattening and
neurite extension in N1E-115 neuroblastoma cells. In inter-
ference assays, Gem opposed ROK
 
 
 
- and Rad opposed
ROK
 
 
 
-mediated cell rounding and neurite retraction. Gem
did not oppose cell rounding initiated by ROK
 
 
 
 containing
a deletion of the Gem binding region, demonstrating that
Gem binding to ROK
 
 
 
 is required for the effects observed.
In epithelial or ﬁbroblastic cells, Gem or Rad expression
resulted in stress ﬁber and focal adhesion disassembly. In
addition, Gem reverted the anchorage-independent growth
and invasiveness of Dbl-transformed ﬁbroblasts. These
results identify physiological roles for Gem and Rad in
cytoskeletal regulation mediated by ROK.
 
Introduction
 
Gem (Cohen et al., 1994; Maguire et al., 1994), Rad (Reynet
and Kahn, 1993), Rem1 (Finlin and Andres, 1997), and
Rem2 (Finlin et al., 2000) are members of a small GTP
binding family of proteins within the Ras superfamily,
sometimes referred to as the RGK* (for Rad, Gem, and the
mouse orthologue of Gem, Kir) family. The basic structure
of RGK proteins consists of a Ras-related core, a non-
CAAX–containing COOH-terminal extension, and NH
 
2
 
-
terminal extensions. The G3 motifs (DXXG) of RGK
proteins are not conserved relative to other small GTPases,
consistent with their low intrinsic GTPase activity (Cohen et
al., 1994; Finlin et al., 2000). The function of RGK proteins
may not be regulated via GTP hydrolysis or, alternatively,
there is a unique molecular mechanism for GTPase activat-
ing protein–catalyzed GTP hydrolysis relative to other Ras
superfamily members. Other potential mechanisms for
modulating RGK protein activity have been described,
including transcriptional regulation (Maguire et al., 1994;
Finlin and Andres, 1997), phosphorylation of the NH
 
2
 
- and
COOH-terminal extensions (Maguire et al., 1994; Moyers
et al., 1998; Finlin and Andres, 1999), 14-3-3 binding (Finlin
and Andres, 1999), calmodulin binding (Fischer et al.,
1996; Moyers et al., 1997), and signal-regulated protein
degradation (Zhu et al., 1996).
Although structural features of the RGK family have been
known for many years, the physiological role of individual
proteins has not been readily forthcoming. Recently, a role
for Gem has been proposed in cells expressing voltage-gated
calcium channels, such as endocrine and neuronal cells.
Gem was reported to down-regulate channel activity as a result
of binding the 
 
 
 
 subunit and thereby inhibiting expression
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of the 
 
 
 
 subunit at the plasma membrane (Beguin et al.,
2001). However, it is likely that Gem has additional roles.
Gem is expressed in cells such as T lymphocytes that do not
contain voltage-gated calcium channels, and furthermore,
Gem has been indirectly implicated in playing a role in cyto-
skeletal reorganization. Overexpression of mouse Gem was
found to induce invasive pseudohyphal growth in 
 
Saccharomy-
ces cerevisiae
 
 (Dorin et al., 1995). Although there is no appar-
ent Gem orthologue in yeast, this assay most likely reflects the
interaction of Gem with a protein common to yeast and mam-
malian cells. Recently, immunofluorescence and cell fraction-
ation studies have localized a portion of Gem to microfila-
ments and microtubules (Piddini et al., 2001). Also, Gem
expression stimulates cell flattening and neurite extension in
human and mouse neuroblastoma cells (Leone et al., 2001).
Other RGK family members are implicated in cytoskeletal
interactions as well. Ges, the likely human orthologue of
mouse Rem1, and Rem1 were recently described to induce
endothelial cell sprouting (Pan et al., 2000). Rad binds
 
 
 
-tropomyosin in skeletal muscle and is associated partially
with the cytoskeleton in C2C12 cells (Zhu et al., 1996; Bi-
lan et al., 1998).
Rho family members regulate the dynamic organization of
cytoskeletal proteins. As described herein, Gem and Rad
bind Rho kinase (ROK), an effector of GTP-bound Rho
that mediates a large proportion of the signals from Rho,
leading to actinomyosin contractility. RhoA-dependent acti-
vation of ROK requires binding via the RhoA effector re-
gion and an additional activation function requiring the
RhoA insert region (Zong et al., 2001). Two isoforms of
ROK exist, referred to as either 
 
 
 
 and 
 
 
 
 or II and I, respec-
tively, with an overall identity of 64% that is greatest in the
kinase domain (90%) and least in the coiled-coil domain
(55%) (Leung et al., 1995, 1996; Ishizaki et al., 1996; Nak-
agawa et al., 1996). Relatively few functional differences be-
tween the two isoforms are known presently. Both isoforms
are ubiquitously expressed in tissues, although ROK
 
 
 
 pre-
dominates in adult brain (Ishizaki et al., 1996; Leung et al.,
1996; Matsui et al., 1996). In addition, ROK
 
 
 
, but not
ROK
 
 
 
, is a substrate for caspase-3 during apoptosis, leading
to a constitutively active kinase that participates in bleb for-
mation (Coleman et al., 2001; Sebbagh et al., 2001).
Several substrates for ROK are known. ROK controls acti-
nomyosin filament assembly and myosin contractile activity
by inducing the phosphorylation of the regulatory myosin
light chain (MLC). Increased MLC phosphorylation results
directly from ROK-mediated phosphorylation of MLC and
indirectly by the inactivation of myosin phosphatase through
ROK-mediated phosphorylation of myosin binding subunit
(MBS) (Amano et al., 1996; Kimura et al., 1996). MLC
phosphorylation is detected after ROK activation and associ-
ated with the formation of stress fibers and focal adhesions
(Amano et al., 1997, 1998; Chihara et al., 1997; Ishizaki et
al., 1997), smooth muscle contraction (Kureishi et al., 1997),
and neurite retraction (Amano et al., 1998; Hirose et al.,
1998). Other ROK substrates include members of the ezrin/
radixin/moesin family, adducin, LIM kinase (LIMK), Na-H
exchanger 1, and intermediate filaments, and the phosphory-
lation state of these proteins appears to be associated with spe-
cific cell functions (for review see Amano et al., 2000).
We show here that Gem binds ROK
 
 
 
 and inhibits ROK-
mediated MLC phosphorylation. Ectopic Gem or Rad expres-
sion inhibits ROK-dependent functions such as formation of
stress fibers and focal adhesions, neurite retraction, and Rho-
dependent transformation. These data suggest that Gem and
Rad perform regulatory functions in cytoskeletal remodeling,
perhaps as spatially regulated inhibitors of ROK activity.
 
Results
 
Yeast two-hybrid analysis
 
To gain insight into its biochemical function, we used Gem
as bait in a yeast two-hybrid analysis of a human B cell li-
brary. A clone encoding a fragment of ROK
 
 
 
 (also called
ROCK I) was identified as interacting strongly with Gem
and was of particular interest in light of various reports sug-
gesting an association between RGK family members and
the cytoskeleton (Dorin et al., 1995; Bilan et al., 1998; Pan
et al., 2000). The ROK
 
 
 
 clone (amino acids [aa] 787–1027)
spanned the COOH-terminal half of the coiled-coil domain
Figure 1. ROK fragments used in two-hybrid assays and referred 
to in Table I. ROK : a (787–1027), b (2–421), c (422–1097), d 
(1098–1354), e (422–933), f (422–727). ROK : a (807–1056), b 
(2–438), c (439–1126), d (1127–1388).
 
Table I. 
 
A yeast two-hybrid assay
 
ROK
 
 
 
 regions bound ROK
 
 
 
 regions bound
 
Gem full-length (2–296) a, c, e
 
 
 
Gem 
 
 
 
c (2–262) a, c, e
 
 
 
Gem core (71–262) a, c, e
 
 
 
Gem(S89N) a, c, e
 
 
 
Rad (41–308)
 
 
 
c
Rad 
 
 
 
c (41–274) a, c, e
 
 
 
Rem1 full-length (2–297)
 
  
 
Rem2 full-length (2–272)
 
  
 
Rem1 
 
 
 
c (2–254)
 
  
 
Rho Q63L a, c a, c
Y190 yeast were transformed with combinations of plasmids expressing Gal4
DNA binding domain–GTP binding protein and Gal4 activation domain–ROK
 
 
 
or ROK
 
 
 
 fragments. The letters refer to the diagrammatic representation of the
various ROK fragments shown in Fig. 1. At least three independent transformants
were assayed in each case. Interactions were considered positive if growth
occurred after 3 d at 30
 
 
 
C on selective medium lacking histidine and containing
at least 2 mM aminotriazole, and if a blue color was observed within 5 min of
initiating an in situ 
 
 
 
-galactosidase assay. 
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and the p21 Rho binding domain (PBD) (Leung et al.,
1996). The interaction of Gem with various regions of
ROK
 
 
 
 was tested further in a two-hybrid assay (Table I and
Fig. 1). Gem did not bind the PBD, PH/CRD, or NH
 
2
 
-ter-
minal kinase domains (Table I) but interacted with the
coiled-coil domain exclusive of the PBD (Table II). In addi-
tion, point mutations introduced at aa 1004 and 1005 in the
PBD were shown to inhibit interaction with Rho, whereas
Gem binding remained intact (Table II). Therefore, Gem
binds to a region of ROK
 
 
 
 adjacent to but distinct from
Rho binding, and the interaction of Gem with ROK
 
 
 
 does
not require Rho binding.
What are the structural features in Gem required for bind-
ing to ROK
 
 
 
? Deletion of the Gem NH
 
2
 
- and COOH-ter-
minal extensions, leaving the Ras homology region core, did
not prevent interaction with ROK
 
 
 
 (Table I). We con-
structed Gem(S89N) based upon the conservation of ho-
mologous serines at positions 17 in Ras and 89 in Gem.
RasS17N is a widely used point mutant with dominant-neg-
ative activity. As shown in Table I, Gem(S89N) bound
ROK
 
 
 
 in the two-hybrid assay.
An important question is the specificity of the Gem–ROK
interaction. Using the yeast two-hybrid system, the interac-
tions of ROK
 
 
 
 and ROK
 
 
 
 with the different RGK family
members (Gem, Rad, Rem1, and Rem2) were determined.
Gem binding appeared to be specific for ROK
 
 
 
, because
various forms of Gem did not bind fragments spanning the
length of ROK
 
 
 
. The length of the Rad construct that was
assayed effected the binding specificity of Rad. Nearly full-
length Rad (41–308) bound the coiled-coil domain of
ROK
 
 
 
 (439–1126) but did not bind various ROK
 
 
 
 frag-
ments or other ROK
 
 
 
 fragments. By contrast, Rad contain-
ing a COOH-terminal deletion (41–274) bound ROK
 
 
 
similarly to Gem (Table I). Neither full-length nor COOH-
terminal truncated Rem1 or Rem2 bound either ROK iso-
form, but full-length Rem1 bound 14-3-3
 
 
 
 (unpublished
data), as reported previously (Finlin and Andres, 1999).
 
Gem–ROK interaction in mammalian cells
 
We also investigated the physical association of Gem and
Rad with ROK (Fig. 2) and determined that binding can be
 
observed. As shown in Fig. 2 A, recombinant glutathione-
 
S
 
-transferase (GST)–Gem and recombinant GST–Rad bound
ROK
 
 
 
 and to a lesser extent ROK
 
 
 
 in whole-cell extracts
derived from transfected COS7 cells. The presence of GTP-
 
 
 
S did not effect the binding efficiency (unpublished data).
In addition, coprecipitation of ROK
 
 
 
 with Gem was ob-
served from extracts of either transfected COS7 or N1E-115
cells (Fig. 2 B), consistent with the interaction seen in the
yeast two-hybrid analyses.
 
Neuroblastoma model
 
The roles of Rho and ROK have been explored extensively
in a model of neuronal differentiation using mouse neuro-
blastoma N1E-115 cells. N1E-115 cells display a heter-
ogeneous morphology with approximately half the cells
rounded and the other half slightly flattened. Activation of
Rho or ROK is necessary and sufficient to stimulate neurite
retraction and extensive cell rounding in N1E-115, whereas,
inhibition of ROK has been shown to lead to neurite exten-
sion (Hirose et al., 1998). To investigate the functional sig-
nificance of the Gem–Rad–ROK interactions, we observed
the effect of transiently expressing various RGK family
members singly or together with ROK isoforms. ROK
 
 
 
 and
ROK
 
 
 
 as well as Gem and Rad are endogenously expressed
in N1E-115 cells (unpublished data).
The functional effect observed after transient transfection
of Gem or Rad suggested an inhibition of ROK activity (Fig.
3, A and B). That is, Gem or Rad individually stimulated
flattening and neurite extension of N1E-115 cells, a pheno-
type that is observed after transfection of dominant-negative
ROK or with the ROK inhibitor Y-27632 (see Fig. 8, A and
B) (Hirose et al., 1998). Correlative with ROK binding in
the yeast two-hybrid assay, Gem or Rad displayed functional
 
Table II. 
 
A yeast two-hybrid assay
Gem core Rad 
 
 
 
c Rho Q63L
 
ROK
 
 
 
 (787–1027)
 
   
 
ROK
 
 
 
 (787–1027) 
[N1004T, K1005T]
 
   
 
ROK
 
 
 
 (787–976)
 
   
 
ROK
 
 
 
 (907–1027)
 
   
 
ROK
 
 
 
 (726–1027, 
 
 
 
787–906)
 
   
 
Y190 yeast were transformed with combinations of plasmids expressing
Gal4 DNA binding domain–GTP binding protein and Gal4 activation
domain–ROK
 
 
 
 fragments. ROK
 
 
 
 (787–976) is adjacent to but does not
include the p21 binding domain. ROK
 
  
 
(907–1027) contains the previously
defined p21 binding domain. At least three independent transformants were
assayed in each case. Interactions were considered positive if growth
occurred after 3 d at 30
 
 
 
C on selective medium lacking histidine and
containing at least 2 mM aminotriazole and if a blue color was observed
within 5 min of initiating an in situ 
 
 
 
-galactosidase assay. Figure 2. Interaction of Gem and ROK. (A) Interactions of Gem 
and Rad with ROK in vitro. Lysates from Cos cells transiently trans-
fected with myc-tagged full-length ROK  or ROK  were incubated 
with purified recombinant GST–Gem (GTP S) or –Rad (GTP S) 
bound to glutathione-Sepharose beads. ROK that cosedimented 
with Gem or Rad was shown by Western blot analysis with anti-myc 
antibody. (B) Interaction of Gem and ROK  in vivo. Cos7 or N1E-115 
cells were cotransfected with ROK  and Gem. Cell lysates were 
subjected to immunoprecipitation with either anti-Gem monoclonal 
antibody or mouse IgG as a control for nonspecificity. Coprecipitated 
ROK  was revealed by Western blot using anti-myc antibody. 
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activity but Rem1 and Rem2 did not. In addition, an inter-
ference assay was used to investigate the specificity of Gem
and Rad for the ROK isoforms. Transfection of either
ROK  or ROK  into N1E-115 cells caused enhanced cell
rounding (Fig. 3, A and B). Previous investigations have
shown that transfected ROK is active in the absence of Rho
binding (Leung et al., 1996). Cotransfection of Gem op-
posed the effects of ROK  but not ROK . Surprisingly,
Figure 3. Effect of RGK family members and ROK on N1E-115 
mouse neuroblastoma phenotype. N1E-115 mouse neuroblastoma 
cells were cotransfected with pEGFP-N1 and the DNA indicated. 
The total amount of DNA was normalized with vector DNA. Data 
presented in the bar graphs with standard deviations are the average 
of at least four independent experiments. (A) Representative round 
(ROK -transfected), flattened/short neurite (Gem-transfected), and 
long neurite (Gem-transfected) morphologies in N1E-115 cells. 
(B) Gem reverses ROK -, whereas Rad reverses ROK -dependent 
neurite retraction. Rem1 and Rem2 are not involved in neurite 
induction. (C) Gem expression opposes neurite retraction stimulated 
by constitutively active RhoA(63L) but has little effect on cell flattening 
caused by the dominant-negative RhoA(19N). Dominant-negative 
Rac(17N) prevents Gem from stimulating cell flattening and neurite 
extension.Gem is a negative regulator of the Rho kinase pathway | Ward et al. 295
cotransfection of Rad fully reversed the activity of ROK 
and only weakly effected ROK . Therefore, in N1E-115
cells, Rad appears to have functional specificity for full-
length ROK , as compared with ROK . Western blots were
used to verify equivalent expression levels for transfected
Gem, ROK , and ROK  in the various experimental condi-
tions depicted in Fig. 3 (unpublished data). The Gem(S89N)
mutant stimulated cell flattening and neurite extension, con-
sistent with its ability to bind ROK . Additionally, Gem and
Rad expression in N1E-115 inhibited lysphosphatidic acid–
induced cell rounding (unpublished data).
Consistent with acting downstream of Rho, Gem opposed
the effect leading to cell rounding stimulated by constitu-
tively active RhoA(63L) and had little effect on the cell flat-
tening stimulated by dominant-negative RhoA(19N) (Fig. 3
C). In addition, the enhancement of cell flattening and neu-
rite extension stimulated by Gem are not observed in the
presence of dominant-negative Rac(17N), demonstrating a
requirement for Rac in the neurite extension observed here.
An important question is whether the inhibitory effects of
Gem and Rad on ROK-mediated functions require the in-
teraction of Gem/Rad with ROK, or, alternatively, are an
indirect effect. To address this question, we have assayed the
ability of Gem or Rad to interfere with cell rounding initi-
ated by ROK mutants missing Gem/Rad binding domains
(Fig. 4 A). Constitutively active ROK  or ROK  truncated
shortly after the kinase domain robustly stimulated round-
ing of N1E-115 cells that was unaffected by Gem or Rad ex-
pression (Fig. 4 A), suggesting that Gem/Rad binding to
ROK is required for inhibition. An additional ROK  mu-
tant, ROK ( 787–906) was constructed by deleting the
Gem binding domain but leaving other regulatory domains
(including the Rho binding domain) intact. This mutant
form of ROK  was stably expressed in COS and N1E-
115 cells (unpublished data). As shown in Fig. 4 A,
ROK ( 787 906) was effective at mediating neurite re-
traction that could not be reversed by Gem expression, fur-
ther supporting the conclusion that Gem and ROK  inter-
act directly.
To further investigate in a functional assay the binding
sites for Gem and Rad on ROK  and ROK , tagged coiled-
coil domains (787–976 for ROK  and 807–1006 for
ROK ) were expressed alone or in combination with Gem
or Rad in N1E-115 cells. As shown in Fig. 4 B, coexpression
of the ROK  or ROK  fragments with Gem or Rad re-
versed their neurite extension activity, consistent with bind-
ing between Gem or Rad and the coiled-coil fragments of
ROK  and ROK . Because the interference assay showed
specificity of Gem for ROK  and Rad for ROK , the deter-
minants of specificity between Gem or Rad and the ROK
isoforms appear to extend beyond the binding fragments.
We tested the possibility that these Gem and Rad binding
domains in the coiled-coil regions of ROK  and ROK 
could act as dominant negatives for endogenous Gem and
Rad. Expression of both protein fragments together in N1E-
115 cells stimulated a small amount of cell rounding (Fig. 4
B), suggesting that Gem and Rad, in addition to other en-
dogenous proteins, are responsible for maintaining the flat-
tened morphology of these cells.
Recently, Gem was shown to bind the   subunit of
L-type Ca
2  channels, resulting in reduced channel activ-
ity due to decreased  1 subunit expression at the plasma
membrane (Beguin et al., 2001). Because N1E-115 cells
express L-type channels, we investigated whether inhibi-
tion of channel activity using nitrendipine would lead to
the morphological alterations induced by Gem. Green
fluorescence protein (GFP)– or GFP–Gem-transfected
N1E-115 cells were treated with nitrendipine (1, 5, 10, or
50  M) for 24 h before being scored for neurite extension.
Nitrendipine had no effect upon the distribution of mor-
phological phenotypes in either GFP- or GFP–Gem-trans-
fected cells (unpublished data), suggesting that inhibition
of channel activity plays no role in the morphological dif-
ferentiation described here.
Figure 4. Gem appears to inhibit ROK  through a direct interaction. N1E-115 mouse neuroblastoma cells were cotransfected with pEGFP-N1 
and the DNA indicated above. The total amount of DNA was normalized with vector DNA. Data presented with standard deviations are the 
average of at least three independent experiments. (A) ROK isoforms missing the Gem/Rad binding domains are not inhibited by coexpression 
of Gem or Rad. (B) Gem- and Rad-induced cell flattening is inhibited by the ROK  (aa 807–1006) and ROK  (aa 787–976) coiled-coil (CC) 
isolated domains.296 The Journal of Cell Biology | Volume 157, Number 2, 2002
The effect of Gem upon the actin cytoskeleton
ROK has been shown to play a fundamental role in the regu-
lation of the actinomyosin cytoskeleton, including the for-
mation of stress fibers and focal adhesions. Therefore, we an-
alyzed the effect of Gem and Rad expression in epithelial
cells and fibroblasts on the cytoskeleton as judged by staining
for F-actin and vinculin (Fig. 5). As shown for HeLa cells in
Fig. 5, transient Gem or Rad overexpression inhibited the
presence of focal adhesions in the main cell body while leav-
ing peripheral focal complexes intact, in agreement with
previous reports that ROK activity is required for the
maintenance of central but not peripheral focal contacts
(Totsukawa et al., 2000). Gem or Rad overexpression in fi-
broblasts often induced an unusual dendritic morphology
(Fig. 5) characterized by abnormal cellular elongation or the
presence of branching filopodial structures and rounding or
retraction of the cell body. Gem or Rad expression was ac-
companied by loss of central but not peripheral focal con-
tacts and loss of stress fibers. In addition, enhanced lamelli-
podia formation was evident in Gem-transfected cells
(unpublished data). Interestingly, a dendritic morphology is
induced in BALB/c 3T3 cells after prolonged inhibition of
RhoA or ROK (Hirose et al., 1998). Low levels of Gem ex-
pression generally did not result in loss of focal adhesions or
stress fibers or induction of a dendritic morphology, possibly
as a result of residual ROK activity.
The effect of Gem upon Rho-dependent transformation 
and invasion
Rho-dependent transformation has been shown to require
ROK signaling for its establishment and maintenance (Sahai
et al., 1998). As one example, 3T3 cells transformed by Dbl
(a Rho guanine nucleotide exchange factor) are inhibited
in anchorage-independent growth by the ROK inhibitor
Y-27632 (Sahai et al., 1999). Therefore, we investigated the
effect of constitutively expressed wild-type and mutant
(S89N) Gem on the ability of Dbl-transformed 3T3 cells to
grow in soft agar. Polyclonal expression of Gem reduced the
ability of Dbl-transformed cells to produce colonies in soft
agar by  60% (Fig. 6 A), consistent with the inhibition of
ROK activity by Gem. Inhibition was observed for both
wild-type and mutant (S89N) Gem, in accordance with
their similar functional activities in neuroblastoma cells.
Gem expression did not affect the growth rate of the Dbl-
transformed cells (unpublished data).
ROK has been shown to play a role in Rho-dependent in-
vasion of hepatocellular carcinoma (Genda et al., 1999; Itoh
et al., 1999). We analyzed the Dbl-transformed 3T3 cells for
their invasive capacity through a matrigel barrier and the ef-
fect of Gem coexpression on this activity. As shown in Fig. 6
B, after transformation by Dbl, 3T3 cells greatly increase
their invasiveness through an extracellular matrix that is in-
hibited  90% by coexpression of Gem or Gem(S89N).
Figure 5. Effect of Gem and Rad on the actin cytoskel-
eton. HeLa and NIH-3T3 cells were transfected with 
Gem or cotransfected with pEGFP-N1 and Rad. The 
cells were analyzed via confocal microscopy. Gem 
was stained with polyclonal anti-Gem antibody and 
FITC-conjugated goat anti–rabbit. Focal adhesions 
were visualized by staining with antivinculin antibody 
and stress fibers were identified with rhodamine-
conjugated phalloidin.Gem is a negative regulator of the Rho kinase pathway | Ward et al. 297
Biochemical analyses
An important question is the mechanism of action
whereby Gem functionally opposes ROK . We consid-
ered the possibilities that Gem (a) inhibits ROK kinase
activity or (b) redirects ROK localization and/or substrate
specificity. We have obtained no evidence suggesting a
direct effect of Gem upon the kinase activity of ROK .
For example, no change in the level of in vitro kinase ac-
tivity was observed in immunoprecipitated ROK  rela-
tive to the presence or absence of coexpressed Gem (un-
published data). Therefore, in order to test the second
possibility, the effect of Gem expression upon the in vivo
activity of ROK  was investigated in COS cells for the
substrates MLC, MBS, and LIMK. ROK-dependent
phosphorylation of MLC and MBS was assayed with
phosphospecific antibodies. LIMK phosphorylation was
measured indirectly by an immune complex kinase activ-
ity assay using cofilin as the substrate. As shown in Fig.
7 A, ROK  stimulated increased phosphorylation of
MLC, which was reversed in the presence of coexpressed
Gem. ROK -mediated phosphorylation was unaffected
by Gem as was phosphorylation mediated by the kinase
domain of ROK  in the absence of the Gem binding re-
gion. Similarly, ROK -dependent phosphorylation of
MBS was inhibited by Gem coexpression (Fig. 7 B). By
contrast, as shown in Fig. 7 C, immunoprecipitated
LIMK demonstrated a ROK-dependent increase in cofi-
lin-directed kinase activity, which was essentially unaf-
fected by coexpressed Gem. Therefore, Gem had a selec-
tive effect on ROK-mediated phosphorylation, inhibiting
MLC and myosin phosphatase phosphorylation, consis-
tent with the opposition by Gem of ROK-activated acti-
Figure 6. Gem inhibits Rho-dependent transformation and invasion. 
NIH-3T3 cells were permanently transfected with Dbl and further 
cotransfected with Gem or Gem(S89N). (A) The ability of the cells 
to form colonies in soft agar (average of three experiments shown) 
and (B) the invasiveness of the cells through matrigel (results are the 
average of five microscopic fields with background subtracted) were 
determined.
Figure 7. Effect of Gem on ROK activity. (A) Gem inhibits ROK - 
but not ROK -dependent phosphorylation of MLC. Cos7 cells were 
transfected with flag-tagged MLC and myc-tagged ROK , ROK , or 
the constitutively active kinase domain of ROK . The ability of Gem 
to inhibit MLC phosphorylation was demonstrated by cotransfection 
with full-length wild-type Gem. Western blots generated with anti-
bodies specific for MLC phosphorylated on serine 19, total trans-
fected MLC detected with antiflag antibodies, or ROK detected with 
anti-myc antibodies are shown. (B) Gem-mediated inhibition of 
MLC phosphatase phosphorylation by ROK  was demonstrated by 
transfection of the MBS into Cos7 cells together with ROK  and/or 
Gem. Western blots generated with antibodies specific for MBS 
phosphorylated on threonine 695 as well as total MBS and ROK are 
shown. (C) Gem has no effect on ROK -dependent LIMK activation. 
HA-tagged LIMK was cotransfected into Cos7 cells with ROK  
and/or Gem and then immunoprecipitated using anti-HA antibody. 
An in vitro kinase assay was performed using cofilin and [ 
32P]ATP 
as substrates for the phosphoryl transfer. Phosphorylated cofilin was 
revealed by autoradiography and ROK protein levels were assayed 
by Western blots.298 The Journal of Cell Biology | Volume 157, Number 2, 2002
nomyosin contractility. These data suggest that Gem
most likely differentially modifies the access of ROK to
its substrates.
Induction of neurites by Gem in N1E-115 cells can be 
partially reversed by an activated form of MLC
To determine whether the inhibition of MLC phosphoryla-
tion was principally responsible for the flattening and neu-
rite extension observed in Gem- and Rad-transfected N1E-
115 cells, we sought to reverse the Gem/Rad effect using a
mutant MLC (T18D,S19D), a mimetic of phosphorylated
MLC. MLC(T18D,S19D) has been shown to lead to the ac-
tivation of myosin ATPase and a conformational change of
myosin II when reconstituted with myosin heavy chains in
vitro (Ikebe and Hartshorne, 1985). As shown in Fig. 8 A,
MLC(18D,19D)–GFP expression enhanced cell rounding
relative to GFP alone (66 as compared with 49%), consis-
tent with previous findings (Amano et al., 1998). The num-
ber of rounded cells observed after Gem or Rad transfec-
tion alone (13 or 13%, respectively) or Y-27632 treatment
alone (10%) was substantially increased ( 45%) upon
MLC(18D,19D) expression. In addition, the morphology
of the flattened cells induced by ROK inhibition was clearly
different in the presence of wild-type MLC–GFP as com-
pared with MLC(18D,19D)–GFP. As shown in Fig. 8 B,
MLC–GFP cells cotransfected with Gem or treated with
Y-27632 (Fig. 8 B) produced highly branched neurites,
whereas MLC(18D,19D)–GFP cells coexpressing Gem (Fig.
8 B) or Rad (unpublished data) or treated with Y-27632
produced flattened bipolar cells. Therefore, cell flatten-
ing and neurite extension resulting from ROK inhibition
by Gem/Rad or Y-27632 can be partially reversed with
MLC(18D,19D) expression.
Discussion
In the present study, we have identified a functional interac-
tion of Gem and Rad with ROK, leading to an inhibition of
ROK-mediated actinomyosin-dependent contractility. Us-
ing the yeast two-hybrid approach, Gem was shown to inter-
act with ROK  in the coiled-coil region, adjacent and
amino-terminal to the Rho binding domain. The interaction
of Gem with ROK  occurred independently of Rho (Tables
I and II). Gem coexpression in cells inhibited ROK -depen-
dent phosphorylation of MLC and the MBS of myosin
phosphatase, events that would be predicted to work cooper-
atively in inhibiting contractility of the actinomyosin cyto-
skeleton. Consistent with this, ectopic Gem expression re-
sulted in physiological changes, suggesting an inhibition of
endogenous ROK function, including the stimulation of cell
Figure 8. Effect of constitutively active MLC on ROK inhibition in 
N1E-115 neuroblastoma. NIE-115 cells were transfected with GFP-
tagged MLC or activated MLC, MLC(18D,19D), along with Gem 
and/or Rad. Y-27632 was used as a control for ROK inhibition. 
The data presented with standard deviation are the average of at 
least four experiments. (A) Percent of cells with round phenotype 
was determined by microscopic examination of transfected cells. 
(B) Confocal scans of representative cells were generated using 
a ZEISS LSM 510.Gem is a negative regulator of the Rho kinase pathway | Ward et al. 299
flattening and neurite extension in N1E-115 cells, loss of
stress fibers and focal adhesions in fibroblasts and epithelial
cells, and inhibition in 3T3 cells of Rho-dependent anchor-
age-independent growth and invasion. In addition, interfer-
ence assays demonstrated Gem inhibition of ROK - but
not ROK -mediated neurite retraction in N1E-115 cells
(Fig. 3 B) and actin filament bundling in HeLa cells (un-
published data). Furthermore, the ability of Gem to inter-
fere with ROK -mediated neurite retraction was dependent
upon the presence of the Gem binding domain in ROK ,
demonstrating that the functional effects of Gem are a result
of its binding to ROK (Fig. 4 A).
There are many parallel functional effects of Gem and
Rad expression, such as the stimulation of neurite extension
and loss of stress fibers and focal adhesions, that suggest in-
hibition of endogenous ROK-dependent actinomyosin con-
tractility. Although a COOH-terminal truncated Rad was
found to bind ROK  in the yeast two-hybrid assay, interfer-
ence assays with full-length Rad and ROK  or ROK  indi-
cated a specificity of Rad for ROK  in the neurite retraction
assay (Fig. 3 B) or in an actin fiber bundling assay in HeLa
cells (unpublished data). The interference data suggest that
the interaction of Rad with ROK isoforms in mammalian
cells may be tightly regulated.
The specificity of Gem for ROK  was observed with re-
gard to binding in the yeast two-hybrid system, biochemical
assays, and functional assays. The significance of this speci-
ficity is currently unknown. To date, relatively few distinc-
tions between potential ROK  and ROK  functions have
been described. One exception is that ROK  is sensitive to
apoptosis-induced caspase-3 cleavage and subsequent consti-
tutive activation, leading to membrane blebbing (Coleman
et al., 2001; Sebbagh et al., 2001). The caspase cleavage site
in ROK  is located at positions 1110–1113, COOH-termi-
nal to the Gem binding region, suggesting that Gem could
influence the outcome of caspase-3 regulation of ROK .
After the introduction of exogenous ROK, Gem inhibits
ROK-dependent phosphorylation of MLC and myosin
phosphatase in situ, but does not appear to inhibit ROK-
dependent activation of LIMK, implying substrate specificity
to the inhibitory function of Gem. Such specificity suggests
that Gem is not affecting a generalized regulatory function
for ROK, such as Rho binding. Thus, the effects of Gem on
transfected ROK appear independent of Rho binding. Al-
though it seems unlikely, we have not formally demon-
strated that the loss of actinomyosin contractility, which oc-
curs in the presence of Gem after activation of the Rho
pathway, could not involve an effect of Gem upon Rho
binding to endogenous ROK.
The in vitro kinase activity of immunoprecipitated ROK
directed against purified MLC or meromyosin is unaffected
by Gem coexpression (unpublished data), suggesting that
Gem does not induce an inhibitory covalent modification of
subsequently purified ROK. Gem may selectively effect the
substrate specificity of ROK as a result of being localized in
the cytoskeletal fraction (Piddini et al., 2001), a possibility
supported by the association of ROK and myosin phos-
phatase with isolated stress fibers containing phosphoryla-
tion-competent MLC (Kawano et al., 1999; Katoh et al.,
2001). Alternatively, Gem binding may obscure a region in
ROK that plays a role in substrate-specific binding. Inhibi-
tion of ROK activity toward selective substrates by Gem
provides a means for fine tuning the response of cytoskeletal
components to ROK and by extension, Rho activation.
Although Rad expression mimics the functional effects of
Gem with regard to inhibiting actinomyosin contractility, it
has not been possible to assign a biochemical mechanism
similar to that of Gem. Cotransfection of ROK and MLC
with Rad resulted in the rapid turnover of MLC protein
(unpublished data), the physiological significance of which
merits further investigation.
Ectopic expression of Gem or Rad in fibroblasts or epithe-
lial cells resulted in a loss of stress fibers and focal adhesions
but not peripheral focal complexes, consistent with previous
reports of the cytoskeletal organization observed after treat-
ment with the ROK inhibitor Y27632 (Rottner et al.,
1999). Peripheral focal complex formation has been shown
to be regulated by Rac activation (Nobes and Hall, 1995)
and dependent upon myosin 2 contractility, whereas focal
complex maturation into focal adhesions is ROK dependent
(Rottner et al., 1999). MLC phosphorylation at the cell pe-
riphery appears to be regulated by MLC kinase (Totsukawa
et al., 2000) but not ROK. Thus, it has been suggested that
ROK plays an important role in maintaining cytoplasmic or
tonic tension within both smooth muscle (Katoh et al.,
2001) and nonmuscle cells (Totsukawa et al., 2000). The
dendritic morphology of fibroblasts induced by Gem or Rad
probably results in part from a loss of cytoplasmic tension
and rounding within the cell body while maintaining adhe-
sion along the cell periphery.
We have observed increased lamellipodia formation in
Gem-expressing cells, indicating that Rac activity may be in-
creased. A mutual antagonism between Rac and Rho path-
ways has been previously proposed in studies on the regula-
tion of neurite extension in neuronal cells (Leeuwen et al.,
1997; Hirose et al., 1998) and actin filament reorganization
in fibroblasts (Moorman et al., 1999). It will be interesting
to determine whether the inhibition of ROK by Gem is ac-
companied by an increase in Rac activity.
What is the expected biological role of Gem and/or Rad
with regard to regulating actinomyosin contractility? The
actin cytoskeleton is central to such cellular processes as
neurite extension, substrate adhesion, motility, secretion,
cellular polarization, and cell cleavage (Carpenter, 2000).
Dynamic processes such as motility and secretion cycle
through periods of assembly and disassembly of the actin cy-
toskeleton. For example, in some cells, movement and posi-
tioning of exocytotic granules requires an intact cytoskele-
ton, whereas cortical F-actin disassembly appears to be a
prerequisite for juxtamembrane apposition of granules and
exocytosis (Muallem et al., 1995; Lang et al., 2000).
The data presented here demonstrating that Gem(S89N)
is functional in ROK inhibition suggest that the effect of
Gem upon ROK  function is regulated by a mechanism
other than differential GTP or GDP binding. Gem expres-
sion is highly responsive to various signaling pathways
(Leone et al., 2001), and both Gem and Rad proteins
are potentially regulated by not only GTP binding but
phosphorylation (Maguire et al., 1994; Moyers et al., 1998;
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as 14-3-3 (Finlin and Andres, 1999) and calmodulin (Fi-
scher et al., 1996; Moyers et al., 1997). In summary, Gem
and Rad provide a mechanism for localized signal-responsive
regulation of the Rho–ROK-mediated assembly and con-
traction of the actin cytoskeleton.
Increased Gem protein levels have been shown to be asso-
ciated with ganglionic differentiation of neuroblastoma in
vivo (Leone et al., 2001), and ectopic Gem expression stim-
ulates neurite extension in vitro (Fig. 3 A and Fig. 7 B), con-
sistent with a potential role for Gem in morphological regu-
lation of neurites/dendrites. Also, recently, binding of the  
subunits of L-, P/Q-, and N-type voltage-gated calcium
channels to Gem was shown to inhibit their transport to the
plasma membrane (Beguin et al., 2001). Interestingly, Rho
and ROK have been reported to control the intracellular lo-
calization of the water channel aquaporin-2 via regulation of
the F-actin cytoskeleton (Klussmann et al., 2001). Inhibi-
tion of Rho or ROK induces translocation of aquaporin-2 to
the plasma membrane, a process that is normally stimulated
by vasopressin and cAMP production. It will be interesting
to determine whether actin filament dynamics and/or regu-
lation of ROK play a role in Gem-regulated transport of the
  subunit.
Materials and methods
Plasmids and antibodies
Affinity-purified antiphosphoserine 19 MLC polyclonal antibody (Mat-
sumura et al., 1998) was from Fumio Matsumura (Rutgers University), and
affinity-purified antiphosphothreonine 695 MYPT1 polyclonal antibody
(pM1333
T695) (Feng et al., 1999) was supplied by Masaaki Ito (Mie Univer-
sity School of Medicine). pEFBos-myc–ROK  was obtained from Kozo
Kaibuchi (Nagoya University Graduate School of Medicine, Aichi, Japan)
and pCAG-myc–ROK  and pCAG-myc–ROK ( 4) were from Shuh Naru-
miya (Kyoto University, Kyoto, Japan). pCAG-myc–ROK ( 787–906) was
made as follows. PCR was used to generate fragments with complementary
ends encoding ROK  (aa 683–786) and ROK  (aa 907–1027). Recombi-
nant PCR was used to generate 683( 787–906)–1027, which was subse-
quently cut with XhoI and SphI and used to replace the wild-type fragment
between the 5  XhoI and SphI sites of pCAG-myc–ROK . The construct
was sequenced and determined to be unchanged outside the deleted re-
gion.
The pEGFPN1-MLC and pCMV-flag–MLC constructs were made using
T7-7-MLC from Kathy Trybus (University of Vermont, Burlington, VT) as a
template. Quik Change site-directed mutagenesis (Stratagene) was used to
generate the pEGFPN1-MLC(18D,19D) mutant. PGex2T-Rad was a gift
from Ron Kahn (Joslin Diabetes Center, Boston, MA) and pEFBos-Rad was
from James Lenhard (Glaxo Wellcome Inc., Research Triangle Park, NC).
PMT2T-Rem1 and -Rem2 were generated by PCR cloning using pGexKG-
Rem1 and -Rem2 (Douglas Andres, University of Kentucky, Lexington, KY)
as templates. pLEGFPN1-M133 was a gift from David Hartshorne (Univer-
sity of Arizona, Phoenix, AZ), and pUCD2-3xHA–LIMK1 and pQE60Amp
r-
His–cofilin were from Kensaku Mizuno (Tohoku University, Sendai, Ja-
pan). pCEV-RhoA63L, -RhoA19N, and -Rac17N were obtained from Silvio
Gutkind (National Cancer Institute, Bethesda, MD) and CTV-Dbl was from
Geoff Clark (National Cancer Institute).
Yeast two-hybrid analysis
All Gal4 DNA binding domain fusions were generated by cloning into
pGBT9 (CLONTECH Laboratories, Inc.). S. cerevisiae strain Y190 (obtained
from Stephen Elledge, Baylor College of Medicine, Houston, TX) was se-
quentially transformed with the pGBT9 full-length Gem bait vector and a
human Raji cDNA library in the GAL4 activation domain vector pACT1
(CLONTECH Laboratories, Inc.) according to the protocols described for
the MATCHMAKER yeast two-hybrid system (CLONTECH Laboratories,
Inc.). Transformants were plated on synthetic complete (SC) plates lacking
Trp, Leu, and His for  3 d. Colonies were rescreened for expression of the
lacZ marker after lifting onto nitrocellulose filters. 5 million colonies were
plated, and 3/27 clones that specifically interacted with Gem were identi-
cal to ROK . For further two-hybrid analyses, DNA fragments were in-
serted into derivatives of pGBT9 and pGAD424. Yeast were cotransformed
by pairs of binding and activation domain plasmids, selected on Trp-, Leu-
deficient SC plates, and subsequently patched to Trp-, Leu-, His-deficient
SC plates containing 2, 25, or 50 mM 3-aminotriazole. Interactions were
assessed by growth after 48 h, and  -galactosidase activity was measured
after transfer to nitrocellulose filters.
Immunofluorescent staining and confocal microscopy
Exponentially growing cells were plated on glass coverslips (A. Daigger &
Co.) in 24-well cell culture dishes and incubated overnight at 37 C and
5% CO2. The next day, cells on each coverslip were transfected with 0.05
 g pEGFP-N1 and 0.5  g pEFBos-Rad or 0.5  g PMT2T-Gem using Lipo-
fectamine Plus (Invitrogen). 24 h later, cells were fixed with 4% parafor-
maldehyde for 10 min at room temperature, rinsed three times with PBS,
and permeabilized with 1% Triton X-100 in 0.02% BSA–PBS for 2 min at
room temperature. Cells were blocked in 20% goat serum containing 2%
BSA–PBS for 20 min at 37 C. Cells transfected with Gem were incubated
for 1 h at room temperature with polyclonal anti-Gem antibody. One half
of the coverslips transfected with Gem or Rad were then incubated with
monoclonal antivinculin antibody (Sigma-Aldrich) for 1 h at room temper-
ature, rinsed three times with PBS, and incubated at room temperature for
30 min with Texas red-X–conjugated goat anti–mouse antibody (Molecular
Probes). The other half of the coverslips were incubated with rhodamine–
phalloidin (Molecular Probes) for 30 min at room temperature. All anti-
bodies were diluted in 2% goat serum in 2% BSA–PBS. After three more
rinses with PBS, coverslips were inverted into 7  l of mounting medium
containing antifade agents (Biomeda Corp.) and were allowed to dry at
room temperature in the dark. Stained cells were examined on a ZEISS Ax-
ioplan microscope equipped with a 100 /1.4 oil immersion objective.
Confocal images were generated using an LSM 510 scanning laser micro-
scope (ZEISS).
N1E-115 neuroblastoma morphology assay
Neurite remodeling was assayed as previously described (Leone et al.,
2001). ROK and Gem expression were assayed by Western blots to deter-
mine relative levels in samples compared for morphology. Data presented
are the average of at least four independent experiments. ROK inhibitor
Y-27632 was obtained from Hiroyuki Sueoka (Welfide Corp, Osaka, Ja-
pan). Cells were treated with 10  M of Y-27632 for 30 min to inhibit ROK.
Transfections were done using Lipofectamine Plus.
Cosedimentation of recombinant Gem and Rad with ROK
Cos7 cells were plated on 10-cm cell culture dishes (2.0   10
6 cells/plate)
and the next day were transfected with pCAG-myc–ROK  (4  g) or pEF-
Bos-myc–ROK  (4  g) using Lipofectamine Plus. Cell lysates were pre-
pared as described below and precleared at 4 C on glutathione-Sepharose
4B (Amersham Pharmacia Biotech) for 30 min. Precleared Cos cell extracts
were incubated at 4 C for 1 h with glutathione-Sepharose beads that were
prebound to 50  g GST–Gem or –Rad and blocked with 500  l Cos cell
lysate from nontransfected cells. The presence of ROK that had formed a
physical complex with Rad or Gem on glutathione-Sepharose was re-
vealed by Western blot analysis as outlined below.
Coimmunoprecipitation and Western blot analysis
Cos7 or N1E-115 cells (2.0 x 10
6 cells/10-cm cell culture plate) were trans-
fected with PMT2T-Gem (2  g) and pCAG-myc–ROK  (2  g) using Lipo-
fectamine Plus. Soluble protein extracts were prepared as previously de-
scribed (Leone et al., 2001) and precleared on 50  l of recombinant
protein G agarose beads (Invitrogen) for 30 min at 4 C. Gem was immuno-
precipitated by incubating 1 ml of precleared lysate (one plate of cells)
with 25  l of packed recombinant protein G agarose beads and 25  g of
anti-Gem monoclonal antibody P7G4 for 2 h at 4 C. Beads were then
washed three times in 40 volumes of lysis buffer. ROK  that cosedimented
with Gem was visualized by Western blot analysis using anti-myc poly-
clonal antibody (Upstate Biotechnology) and chemiluminescence (Pierce
Chemical Co.).
Soft agar colony forming assay
NIH 3T3 cells were permanently transfected with CTV vector or CTV-
hemagglutinin (HA)–Dbl and polyclonal populations were selected with
hygromycin (300  g/ml). Selected cells were checked for Dbl expression
using Western blot analysis with monoclonal anti-HA antibody (Roche
Molecular Biochemicals) and were then transfected with pRCCMV vector,
pRCCMV-Gem, or pRCCMV-Gem(S89N). These cells were selected with
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by Western blot. Dbl expression was the same in cells with empty pRC-
CMV vector and those transfected with pRCCMV-Gem or -Gem(S89N).
Cells were assayed for their ability to form colonies in soft agar using the
method of Cox and Der (1994).
In vitro invasion assay
Invasion capability of cells was determined as described previously (Ward
et al., 2001). 10% FBS was used as the chemoattractant.
Phosphorylation of MLC and MLC phosphatase (MBS)
Cos7 cells were cotransfected with 2  g pCEV-flag–MLC and empty vector
or 2  g PMT2T-Gem and/or 1  g pEFBos-ROK , pCAG-ROK , or pCAG-
ROK ( 4) using Lipofectamine Plus. Transfected cells were TCA precipi-
tated with 5% TCA (2 mM DTT) and MLC was extracted with urea sample
buffer (20 mM Tris, 22 mM glycine, 10 mM DTT, 8.3 mM urea, 0.1% bro-
mophenol blue). Extract was filtered through a 0.45- m centrifugal filter
(Millipore), and proteins were resolved on a 15% SDS-polyacrylamide gel.
Phosphorylated and total MLC were detected by Western blot analysis us-
ing antiphosphoserine 19 MLC polyclonal antibody and anti–flag M5
(Sigma-Aldrich) respectively. The effect of Gem on MBS phosphorylation
was determined using the same procedure except that cells were trans-
fected with pLEGFPN1-M133 instead of MLC, and pM1333
T695 polyclonal
and antimyosin phosphatase polyclonal (Berkeley Antibody Company) an-
tibodies were used to detect phosphorylated and total MBS, respectively.
LIMK activity assay
Cos7 cells were cotransfected with 1  g pUCD2-3xHA–LIMK1 and empty
vector or 3  g PMT2T-Gem and/or 1  g pCAG-myc–ROK . The effect of
Gem on ROK-dependent phosphorylation of LIMK1 was determined using
the in vitro kinase assay of Ohashi et al. (2000).
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